Yoga and PT show promise in easing pain for breast cancer patients on hormone therapy

NCT ID NCT04457895

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a program combining physical therapy, yoga, and patient education can reduce joint and muscle pain caused by hormone therapy in breast cancer patients. About 108 women with non-metastatic breast cancer and moderate-to-severe pain will be randomly assigned to either the yoga-PT program or standard care. The goal is to see if the program helps patients lower their pain and improve their quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CH Libourne

    RECRUITING

    Libourne, Aquitaine, 33500, France

    Contact Email: •••••@•••••

  • CHU Nîmes

    RECRUITING

    Nîmes, Herault, 30029, France

    Contact Email: •••••@•••••

  • Icm Val D'Aurelle

    RECRUITING

    Montpellier, Herault, 34298, France

    Contact Email: •••••@•••••

  • Insitut de Cancérologie de Lorraine

    RECRUITING

    Vandœuvre-lès-Nancy, Meurthe-et-Moselle,, 54519, France

    Contact Email: •••••@•••••

  • Institut Bergonié

    RECRUITING

    Bordeaux, New Aquitaine, 33076, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institut de Cancérologie de l'Ouest

    RECRUITING

    Angers, Pays de la Loire Region, 49055, France

    Contact Email: •••••@•••••

  • Institut du sein Basque

    RECRUITING

    Tosse, New Aquitaine, 40230, France

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.